166 related articles for article (PubMed ID: 31952435)
21. Exploring the cancer-testis antigen BORIS to design a novel multi-epitope vaccine against breast cancer based on immunoinformatics approaches.
Mahdevar E; Safavi A; Abiri A; Kefayat A; Hejazi SH; Miresmaeili SM; Iranpur Mobarakeh V
J Biomol Struct Dyn; 2022 Sep; 40(14):6363-6380. PubMed ID: 33599191
[TBL] [Abstract][Full Text] [Related]
22. Immunization with placenta-specific 1 (plac1) induces potent anti-tumor responses and prolongs survival in a mouse model of melanoma.
Rahdan S; Razavi SA; Shojaeian S; Shokri F; Amiri MM; Zarnani AH
Adv Med Sci; 2022 Sep; 67(2):338-345. PubMed ID: 36084365
[TBL] [Abstract][Full Text] [Related]
23. Design of a new multi-epitope vaccine against
Chen Z; Zhu Y; Sha T; Li Z; Li Y; Zhang F; Ding J
Epidemiol Infect; 2021 May; 149():e136. PubMed ID: 34032200
[TBL] [Abstract][Full Text] [Related]
24. Immunoinformatics design of a novel epitope-based vaccine candidate against dengue virus.
Fadaka AO; Sibuyi NRS; Martin DR; Goboza M; Klein A; Madiehe AM; Meyer M
Sci Rep; 2021 Oct; 11(1):19707. PubMed ID: 34611250
[TBL] [Abstract][Full Text] [Related]
25. Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma.
Hayashi R; Nagato T; Kumai T; Ohara K; Ohara M; Ohkuri T; Hirata-Nozaki Y; Harabuchi S; Kosaka A; Nagata M; Yajima Y; Yasuda S; Oikawa K; Kono M; Kishibe K; Takahara M; Katada A; Hayashi T; Celis E; Harabuchi Y; Kobayashi H
Oncoimmunology; 2020 Dec; 10(1):1856545. PubMed ID: 33457076
[TBL] [Abstract][Full Text] [Related]
26. 3CL hydrolase-based multiepitope peptide vaccine against SARS-CoV-2 using immunoinformatics.
Jakhar R; Kaushik S; Gakhar SK
J Med Virol; 2020 Oct; 92(10):2114-2123. PubMed ID: 32379348
[TBL] [Abstract][Full Text] [Related]
27. Computational characterization of epitopic region within the outer membrane protein candidate in
Bhattacharya M; Malick RC; Mondal N; Patra P; Pal BB; Patra BC; Kumar Das B
J Biomol Struct Dyn; 2020 Feb; 38(2):450-459. PubMed ID: 30744535
[TBL] [Abstract][Full Text] [Related]
28. Computer aided novel antigenic epitopes selection from the outer membrane protein sequences of Aeromonas hydrophila and its analyses.
Bhattacharya M; Sharma AR; Sharma G; Patra P; Mondal N; Patra BC; Lee SS; Chakraborty C
Infect Genet Evol; 2020 Aug; 82():104320. PubMed ID: 32298854
[TBL] [Abstract][Full Text] [Related]
29. Multi-epitope DnaK peptide vaccine against S.Typhi: An in silico approach.
Verma S; Sugadev R; Kumar A; Chandna S; Ganju L; Bansal A
Vaccine; 2018 Jun; 36(28):4014-4022. PubMed ID: 29861180
[TBL] [Abstract][Full Text] [Related]
30. PLAC1: biology and potential application in cancer immunotherapy.
Mahmoudian J; Ghods R; Nazari M; Jeddi-Tehrani M; Ghahremani MH; Ghaffari-Tabrizi-Wizsy N; Ostad SN; Zarnani AH
Cancer Immunol Immunother; 2019 Jul; 68(7):1039-1058. PubMed ID: 31165204
[TBL] [Abstract][Full Text] [Related]
31. Identification of B and T cell epitope based peptide vaccine from IGF-1 receptor in breast cancer.
Mahdavi M; Moreau V; Kheirollahi M
J Mol Graph Model; 2017 Aug; 75():316-321. PubMed ID: 28628857
[TBL] [Abstract][Full Text] [Related]
32. Induction of Humoral and Cellular Immune Responses in Mice by Multiepitope Vaccines Composing of Both T and B Lymphocyte Epitopes of MAGE-A3 which are Recombined into HBcAg.
Chen Q; Li W; Wang P; Shao H; Ding Y; Wang W; Cen D; Cai Y; Xue X; Zhang L; Zhu G
Protein Pept Lett; 2017; 24(10):947-954. PubMed ID: 28641561
[TBL] [Abstract][Full Text] [Related]
33. A reverse vaccinology and immunoinformatics approach for designing a multiepitope vaccine against SARS-CoV-2.
Jahangirian E; Jamal GA; Nouroozi M; Mohammadpour A
Immunogenetics; 2021 Dec; 73(6):459-477. PubMed ID: 34542663
[TBL] [Abstract][Full Text] [Related]
34. Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccine.
Ohtake J; Ohkuri T; Togashi Y; Kitamura H; Okuno K; Nishimura T
Immunol Lett; 2014 Sep; 161(1):20-30. PubMed ID: 24794408
[TBL] [Abstract][Full Text] [Related]
35. Vaccinomic approach for novel multi epitopes vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Almofti YA; Abd-Elrahman KA; Eltilib EEM
BMC Immunol; 2021 Mar; 22(1):22. PubMed ID: 33765919
[TBL] [Abstract][Full Text] [Related]
36. In silico designing of a novel polyvalent multi-subunit peptide vaccine leveraging cross-immunity against human visceral and cutaneous leishmaniasis: an immunoinformatics-based approach.
Bhattacharjee M; Banerjee M; Mukherjee A
J Mol Model; 2023 Mar; 29(4):99. PubMed ID: 36928431
[TBL] [Abstract][Full Text] [Related]
37. Immunoinformatics guided rational design of a next generation multi epitope based peptide (MEBP) vaccine by exploring Zika virus proteome.
Shahid F; Ashfaq UA; Javaid A; Khalid H
Infect Genet Evol; 2020 Jun; 80():104199. PubMed ID: 31962160
[TBL] [Abstract][Full Text] [Related]
38. Structural basis and designing of peptide vaccine using PE-PGRS family protein of Mycobacterium ulcerans-An integrated vaccinomics approach.
Nain Z; Karim MM; Sen MK; Adhikari UK
Mol Immunol; 2020 Apr; 120():146-163. PubMed ID: 32126449
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the DosR regulon genes to select cytotoxic T lymphocyte epitope specific vaccine candidates using a reverse vaccinology approach.
Pandey K; Sharma M; Saarav I; Singh S; Dutta P; Bhardwaj A; Sharma S
Int J Mycobacteriol; 2016 Mar; 5(1):34-43. PubMed ID: 26927988
[TBL] [Abstract][Full Text] [Related]
40. In silico analysis and expression of a novel chimeric antigen as a vaccine candidate against Toxoplasma gondii.
Dodangeh S; Fasihi-Ramandi M; Daryani A; Valadan R; Sarvi S
Microb Pathog; 2019 Jul; 132():275-281. PubMed ID: 31078709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
